Epcoritamab with rituximab + lenalidomide (R2) and epcoritamab maintenance deliver deep and durable remissions in previously untreated (1L) follicular lymphoma (FL): 3-year outcomes from epcore NHL-2 arms 6 and 7
Fields of Study & Subjects
Lymphoma Diagnosis and Treatment
Chronic Lymphocytic Leukemia Research
Cutaneous lymphoproliferative disorders research
Publication details
- Journal / source
- University of Southern Denmark Research Portal (University of Southern Denmark)
- Publication date
- 21 January 2026
- Language
- EN